American Society Of Pediatric Hematology/Oncology

Is American Society Of Pediatric Hematology/Oncology Legit?

Some Concerns

Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →

American Society Of Pediatric Hematology/Oncology directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.

About American Society Of Pediatric Hematology/Oncology

American Society Of Pediatric Hematology/Oncology (EIN: 112564191) is a nonprofit organization based in Schaumburg, IL, classified under NTEE code G31Z. The organization reported total revenue of $2.8M and total assets of $4.2M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of American Society Of Pediatric Hematology/Oncology's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.

Organization Overview

American Society Of Pediatric Hematology/Oncology is a mid-size nonprofit that has been operating for 32 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 6.4%.

Key Financial Metrics (2023)

From the most recent IRS 990 filing on record:

Financial Health Grade: A

In 2023, American Society Of Pediatric Hematology/Oncology reported a surplus of $307K with revenue exceeding expenses, holds 17.2 months of operating reserves (strong position), has a debt-to-asset ratio of 20.1% (moderate leverage).

Financial Trends

Over 13 years of filings (2011–2023), American Society Of Pediatric Hematology/Oncology's revenue has grown at a compound annual growth rate (CAGR) of 6.4%.

IRS Tax-Exempt Classification

Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.

AI Transparency Report

Mission Effectiveness Score

NonprofitSpending's AI analysis rates American Society Of Pediatric Hematology/Oncology with a Mission Score of 90 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.

Spending Breakdown

• admin: 10%
• programs: 85%
• fundraising: 5%

According to IRS 990 filings, American Society Of Pediatric Hematology/Oncology allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.

Key Financial Metrics (2023)

From the most recent IRS 990 filing on record:

• The organization reported a surplus of $307K, with revenue exceeding expenses.
• Debt-to-asset ratio: 20.1%.

Executive Compensation Analysis

Executive compensation is reported as 0% across all available filings, indicating that no officers receive compensation from the organization, which is highly unusual for an organization with revenues exceeding $2 million annually and suggests a strong dedication to mission over executive pay.

Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.

Red Flags

The following concerns were identified during AI analysis of American Society Of Pediatric Hematology/Oncology's IRS 990 filings:

• Lack of detailed program, administrative, and fundraising expense breakdown in provided summary data, making precise efficiency analysis difficult.

Strengths

The following positive indicators were identified for American Society Of Pediatric Hematology/Oncology:

• Consistent financial surpluses, indicating sound financial management (e.g., $306,916 surplus in 2023).
• Significant growth in assets over the past decade, from $1,626,382 in 2014 to $3,586,041 in 2023.
• Zero reported officer compensation across all filings, demonstrating exceptional dedication to mission and efficient use of funds.
• Consistent filing of IRS 990s, indicating strong transparency and compliance.
• Manageable liabilities relative to assets, suggesting financial stability.

Frequently Asked Questions about American Society Of Pediatric Hematology/Oncology

Filing History

IRS 990 filing history for American Society Of Pediatric Hematology/Oncology showing financial trends over 13 years of public records:

Over 13 years of IRS 990 filings (2011–2023), American Society Of Pediatric Hematology/Oncology's revenue has grown by 110.4%, moving from $1.3M to $2.8M. Total assets increased by 334.2% over the same period, from $826K to $3.6M. Total functional expenses rose by 95.4%, from $1.3M to $2.5M. In its most recent filing year (2023), American Society Of Pediatric Hematology/Oncology reported a surplus of $307K, with revenue exceeding expenses. The organization holds $720K in liabilities against $3.6M in assets (debt-to-asset ratio: 20.1%), resulting in net assets of $2.9M.

Year-by-Year Financial Summary

• 2023: Revenue of $2.8M, expenses of $2.5M, and assets of $3.6M (revenue +25.6% year-over-year).
• 2022: Revenue of $2.2M, expenses of $2.2M, and assets of $3.1M (revenue -8.0% year-over-year).
• 2021: Revenue of $2.4M, expenses of $1.8M, and assets of $3.2M (revenue +46.7% year-over-year).
• 2020: Revenue of $1.7M, expenses of $1.6M, and assets of $2.9M (revenue -41.6% year-over-year).
• 2019: Revenue of $2.8M, expenses of $2.4M, and assets of $2.5M (revenue +34.4% year-over-year).
• 2018: Revenue of $2.1M, expenses of $2.1M, and assets of $2.3M (revenue -15.0% year-over-year).
• 2017: Revenue of $2.5M, expenses of $2.2M, and assets of $2.2M (revenue +20.8% year-over-year).
• 2016: Revenue of $2.1M, expenses of $1.9M, and assets of $2.0M (revenue -4.8% year-over-year).
• 2015: Revenue of $2.2M, expenses of $2.0M, and assets of $1.6M (revenue +20.4% year-over-year).
• 2014: Revenue of $1.8M, expenses of $1.7M, and assets of $1.6M (revenue -7.7% year-over-year).
• 2013: Revenue of $1.9M, expenses of $1.7M, and assets of $1.4M (revenue +45.5% year-over-year).
• 2012: Revenue of $1.3M, expenses of $1.3M, and assets of $1.3M (revenue +0.0% year-over-year).
• 2011: Revenue of $1.3M, expenses of $1.3M, and assets of $826K.

View Individual Filing Years

Explore detailed financial data from each IRS 990 filing year for American Society Of Pediatric Hematology/Oncology:

Data Sources and Methodology

This transparency report for American Society Of Pediatric Hematology/Oncology is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.

IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.